Holen Sie sich die Stockscreener-App
1.94
0.52%
0.01
Handel nachbörslich:
1.94
Schlusskurs vom Vortag:
$1.93
Offen:
$1.93
24-Stunden-Volumen:
35,959
Relative Volume:
1.99
Marktkapitalisierung:
$6.18M
Einnahmen:
$8,700
Nettoeinkommen (Verlust:
$-8.49M
KGV:
-0.3935
EPS:
-4.9303
Netto-Cashflow:
$-7.39M
1W Leistung:
-4.90%
1M Leistung:
-6.73%
6M Leistung:
-34.46%
1J Leistung:
-43.42%
1-Tages-Spanne:
$1.85
$2.0999
1-Wochen-Bereich:
$1.80
$2.0999
52-Wochen-Spanne:
$1.80
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Firmenname
Heartsciences Inc
Sektor
Branche
Telefon
682-237-7781
Adresse
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
1.94 | 6.15M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc Aktie (HSCS) Neueste Nachrichten
What HeartSciences (HSCS) accounting reveals about the business | Q1 2026: EPS Tops ViewsCommunity Volume Signals - newser.com
HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataHot Market Picks - newser.com
The technology investments behind HeartSciences (HSCSW) growth | HSCSW Q1 Earnings: HeartSciences Revenue Data UnavailableCommunity Watchlist - newser.com
HSCSW HeartSciences quarterly results show strategic progress as innovation pipeline drives growth, CEO upbeat on outlook.Cyclicality - newser.com
HeartSciences Inc. 2026 Annual Meeting 8-K Filing: Company Details, Stockholder Votes, and Corporate Governance Updates - Minichart
HeartSciences Stockholders Approve Director Election and Equity Plan - TipRanks
HeartSciences (NASDAQ: HSCS) 2026 meeting backs director, auditor, adjournment - Stock Titan
HeartSciences signs first SaaS revenues agreement following full launch of MyoVista Insights(TM) - marketscreener.com
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - The Manila Times
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights - Weekly Voice
Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights - TradingView
Colorado hospital becomes first paying MyoVista Insights customer - Stock Titan
HeartSciences signs first SaaS revenue deal with St. Vincent Health for MyoVista Insights platform. - Pluang
HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops ViewsDirect Listing - Cổng thông tin điện tử tỉnh Lào Cai
HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly.Debt Refinancing - UBND thành phố Hải Phòng
HSCS (HeartSciences) shares drop 3.2 percent despite Q1 2026 EPS beat as revenue plummets year over year.Dividend Suspension - Cổng thông tin điện tử tỉnh Tây Ninh
HeartSciences (HSCS) Stock Prediction: What’s Next After Recent Move (Breakdown Watch) 2026-04-20 - newser.com
HeartSciences (HSCS) Stock: Why Options Traders Watch It (Marginal Gain) 2026-04-15Insider Selling - Cổng thông tin điện tử Tỉnh Sơn La
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting - 富途牛牛
HeartSciences shareholders have until April 29 to vote online - Stock Titan
Growth Report: Does HeartSciences Inc offer margin of safety2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Can HeartSciences (HSCS) Stock Reach New Highs | Price at $2.29, Up 0.66%Most Discussed Stocks - newser.com
Is HeartSciences (HSCS) Stock Slowing Down | Price at $2.26, Down 1.74%Stock Entry Points - newser.com
HeartSciences Announces Passing of COO Mark Hilz; No Changes to Product Plans or Leadership Structure - Minichart
HeartSciences reports passing of COO Mark Hilz, will not seek immediate replacement - Investing.com Australia
HeartSciences COO and Longtime Board Member Passes Away - TipRanks
HeartSc's COO Mark Hilz dies; served on board since 2013 - TradingView
HeartSciences (HSCS) announces death of COO and director, affirms business plans - Stock Titan
Aug Highlights: Is HeartSciences Inc in a long term uptrend2026 Selloffs & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Exit Recap: Can HeartSciences Inc Equity Warrant outperform under higher oil prices2026 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
Aug Retail: Can HeartSciences Inc expand its profit margins2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Big Picture: Will HeartSciences Inc Equity Warrant benefit from geopolitical trendsGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
HSCSW SEC FilingsHeartSciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category - The Manila Times
HeartSciences lands Epic Toolbox spot for ECG workflow software - Stock Titan
APPlife Digital Solutions, Inc. Announces Weekly Investor Update Calls to Enhance Transparency and Shareholder Engagement - Weekly Voice
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings - The Manila Times
HeartSciences Inc. to Present at Investor Summit Group Virtual Conference on March 25, 2026 - Quiver Quantitative
HeartSciences CEO to outline strategy in virtual investor meetings - Stock Titan
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
HSCS Receives Analyst Rating Update: Price Target Lowered by Asc - GuruFocus
Aug Update: What drives HeartSciences Inc Equity Warrants stock price2026 Outlook & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
If You Invested $1,000 in HeartSciences Inc (HSCS) - Stock Titan
Growth Report: Can HeartSciences Inc Equity Warrant ride the EV waveStop Loss & Real-Time Buy Signal Notifications - baoquankhu1.vn
HeartSciences (NASDAQ: HSCS) seeks approval for larger equity plan and officer shield - Stock Titan
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
HeartSciences Reports Q3 2026 Results, Provides Business Update - National Today
HeartSciences Inc. Reports Fiscal Third Quarter 2026 Financial Results and Progress on MyoVista Insights™ Platform - Quiver Quantitative
HeartSciences (NASDAQ: HSCS) posts fiscal Q3 2026 results and files FDA 510(k) - Stock Titan
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - The Globe and Mail
HeartSciences (NASDAQ: HSCS) posts Q3 loss and flags going concern risk - Stock Titan
Finanzdaten der Heartsciences Inc-Aktie (HSCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):